Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03290534
PHASE2
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
Sponsor: CivaTech Oncology
View on ClinicalTrials.gov
Summary
This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2019-03-13
Completion Date
2027-12
Last Updated
2025-04-04
Healthy Volunteers
No
Interventions
DEVICE
CivaSheet
implanting CivaSheet for localized radiation dose delivery
Locations (1)
NYU Langone Health
New York, New York, United States